x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

ACR Journals On Air

American College of Rheumatology

Welcome to "ACR Journals on Air," the ACR"s newest podcast series featuring interviews, commentary, and analysis on research from our three peer-reviewed journals. Join us each episode for engaging discussions with authors and independent experts about recently published studies, their implications for clinical care, and how they move the field of rheumatology forward. Whether it"s an expert analysis of a manuscript or deep dive with an author – our goal is the same – to understand the impact of

health & fitness medicine

All Episodes

40:15

Challenges of COVID

ACR Journals On Air ·

2023/08/08

It has only been three years since the start of the COVID-19 pandemic and we’re only just now beginning to investigate the impact it has had on our collective societies. The full impact will likely not be known for years to come, if ever. As those studies are beginning, our next guests wanted to evaluate the pandemic’s impact in their spheres of interest. First author, Dr. Kristie Kuhn, MD, PhD along with Dr. Liana Fraenkel, MD, MPH and team asked the question: “What is the impact of COVID on our

en

32:32

Pain and Precision Medicine

ACR Journals On Air ·

2023/07/25

This week, we take a look at the practical management of pain and the advancement of science regarding it, with our guest Dr. Dan Clauw. Co-author of the paper: “Identifying and Managing Nociplastic Pain in Individuals With Rheumatic Diseases: A Narrative Review”, Dr. Clauw joins us today to discuss the work to introduce the three types of pain classified by “The International Association for the Study of Pain” and the mechanisms that underlie pain, as it relates to the field of rheumatology.

en

27:25

Delivery Outcomes in Lupus

ACR Journals On Air ·

2023/07/11

Our guest this week is Dr. April Barnado, the first author of a study which analyzed a cohort of 3.2 million patients with Systemic Lupus Erythematosus (SLE), during pregnancy, from 1989 to 2020. Her team’s work, titled “Systemic Lupus Erythematosus Delivery Outcomes Are Unchanged Across Three Decades“ was published in “ACR Open Rheumatology”, and found some amazing trends regarding outcomes of the pregnancies and even in medication use. The study, its methods, conclusions and Dr. Barnado’s advice

en

47:52

Genetics, Constantly Evolving

ACR Journals On Air ·

2023/06/27

Our guest this week is Dr. Tony Merriman, whose latest work: “Association of Gout Polygenic Risk Score With Age at Disease Onset and Tophaceous Disease in European and Polynesian Men With Gout“, attempted to determine whether a gout polygenic risk score (PRS) is associated with age at gout onset and tophaceous disease in European, East Polynesian, and West Polynesian men and women with gout. However, what this study found regarding the predictability of these associations, specifically how it

en

44:34

The Heart of the Matter

ACR Journals On Air ·

2023/06/13

This week we get to “The Heart of the Matter” a little differently. To begin, our guest is the first author of a manuscript whose objective was to determine the prevalence and correlation of subclinical myocardial inflammation in patients with rheumatoid arthritis (RA), titled: “Myocardial Inflammation, Measured using 18-FDG-PET-CT is associated with Disease Activity in Rheumatoid Arthritis“. Her name is Dr. Isabelle Amigues, and her story of survival and reinvention (much like the conclusions of

en

23:57

How Squishy Are Your Cells?

ACR Journals On Air ·

2023/05/30

Our guest this week, Dr. Alexandru-Emil Matei, is the first author of a study that endeavored to evaluate immune cell activation in scleroderma. His study, written for the completion of his medical training in Romania is titled: “Identification of a Distinct Monocyte-Driven Signature in Systemic Sclerosis Using Biophysical Phenotyping of Circulating Immune Cells“ (recently published in “Arthritis & Rheumatology”) performed biophysical phenotyping of circulating immune cells by employing a novel

en

39:07

Less is More

ACR Journals On Air ·

2023/05/16

Caring for older adults who suffer from rheumatic disease comes with it the need to manage multimorbidity, polypharmacy, and geriatric syndromes. Often, shifting priorities for those suffering with rheumatic musculoskeletal diseases (RMDs) is needed, sometimes leading to a prescribing cascade. The practice of ‘deprescribing’, an approach to optimize medication use to deliver a more ‘goal-concordant’ type of care was the focus of Dr. Una Makris and Dr. Jiha Lee’s latest research: “Optimizing

en

39:54

Location, Location, Location

ACR Journals On Air ·

2023/05/02

In a study recently published in “ACR Open Rheumatology” titled: “Geographic Variation in Disease Burden and Mismatch in Care of Patients With Rheumatoid Arthritis in the United States“, first author Dr. Sharon Dowell set out to understand some of the factors associated with regional variation of rheumatoid arthritis in the United States. Sharon Dowell, MD presents her study’s findings and conclusions. ACR’s RISE Team member, Tracy Johansson, MS, joins us as well to discuss how RISE attempts to

en

32:10

SSc Pulmonary Hypertension

ACR Journals On Air ·

2023/04/18

Pulmonary hypertension (PH), being a serious complication of systemic sclerosis (SSc), develops late in the course of SSc and carries with it a poor prognosis. With the median survival of about 3 years, new evidence suggests that early diagnosis and treatment can significantly improve survival. Joining us this week is Christopher P Denton PhD FRCP, senior author of “Dynamic Prediction of Pulmonary Hypertension in Systemic Sclerosis Using Landmark Analysis,” published in Arthritis and Rheumatology

en

20:13

Uric Acid: How Low Can You Go

ACR Journals On Air ·

2023/04/04

Dr. Joshua Baker, first author of a paper recently published in “Arthritis & Rheumatology”, “Associations Between Low Serum Urate, Body Composition, and Mortality“, is our guest today. Dr. Baker, recognizing the controversy in whether low serum urate or uric acid (UA) level contribute to adverse outcomes, set out to evaluate the relation between low serum UA levels and sarcopenia, to assess whether sarcopenia confounds associations between these low levels and mortality.

en

37:13

RheumMadness

ACR Journals On Air ·

2023/03/21

When rheumatology concepts battle it out in a team bracket tournament, you get “Rheum Madness”! “A place for everyone who is crazy about rheumatology to connect, collaborate and compete” in an online, learning experience, created by Dr. David Leverenz. His body of work, “Rheum Madness: Creating an Online Community of Inquiry”, featured in this episode, analyzes participant engagement and the presence of the online community of inquiry within its first year. Dr. Leverenz is an educator and

en

33:19

Partnering For New Models of OA Care

ACR Journals On Air ·

2023/03/07

Osteoarthritis is incredibly common, affecting more than 500 million people across the globe. It is a significant cause of pain and disability and carries high healthcare costs and societal burdens. Around the world, there are not enough rheumatology specialists to treat all the patients with OA, and in many countries, OA management is coordinated by primary care internists. However, despite good guidelines recommending first-line evidence-based treatments with muscle strengthening, physical

en

29:18

A.I. Has Promise in RA

ACR Journals On Air ·

2023/02/21

In this week’s episode, we’ll be looking at a paper recently published in “ACR Open Rheumatology” titled: “Machine Learning Applied to Patient-Reported Outcomes to Classify Physician-Derived Measures of Rheumatoid Arthritis Disease Activity“. This study used machine learning tools to investigate whether longitudinal patient-reported outcome data can be a proxy for Clinical Disease Activity Index (CDAI), presenting interesting findings that may impact the practice of rheumatology. Our guest this

en

34:10

Supporting International Graduates in Rheumatology

ACR Journals On Air ·

2023/02/07

This week, we welcome Dr. Ruth Fernandez Ruiz to our show, a physician-scientist and Assistant Professor of Medicine at Weill Cornell Medical College and Hospital for Special Surgery in New York City. Dr. Fernandez Ruiz’s award-winning work focuses on the interplay of genetic variation, type I interferons, and immune dysregulation in lupus. However, her latest study published in “Arthritis & Rheumatology” entitled: Supporting International Medical Graduates in Rheumatology: A Call to Action seeks to

en

23:44

Sleep Disorders Among Patients with Rheumatoid Arthritis

ACR Journals On Air ·

2023/01/24

Dr. Patricia Katz is our guest this week as she presents her latest study “Sleep Disorders among Individuals with Rheumatoid Arthritis”, recently published in “Arthritis Care & Research”. This study focuses on patients with RA who self-report common sleep problems such as obstructive sleep apnea, restless leg syndrome and short sleep and examines the prevalence of these disorders plus their potential negative health implications. Dr. Katz shares with us her methods, findings and conclusions as well

en

25:02

The TULIP Study, Three Years On

ACR Journals On Air ·

2023/01/10

In this episode, Dr. Shanmugam discusses “A Randomized, Placebo-controlled Phase 3 Extension Trial of Long-term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus”, a three-year long-term study designed to understand the safety of anifrolumab in patients with systemic lupus erythematosus (SLE). This study, which was recently published in “Arthritis & Rheumatology”, represents the longest placebo-controlled clinical trial performed in SLE to date. She is joined by our

en

27:40

Ticking the Boxes

ACR Journals On Air ·

2022/12/27

In this episode, we welcome the lead author of “Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A phase 2, Randomized, Double-Blind, Placebo-Controlled Trial” Dr. Eric Morand of Monash University. The objective of this multicenter clinical trial in lupus (recently published in “Arthritis & Rheumatology”) was to assess the efficacy of deucravacitinib in a phase II trial in adult patients with active lupus. Dr. Morand’s methods, results and ultimate conclusions take

en

32:27

If you can’t feel it, does it hurt?

ACR Journals On Air ·

2022/12/13

Join us this week as we interview the lead author of “Genicular Nerve Block for Pain Management in Patients with Knee Osteoarthritis: A Randomized Placebo-Controlled Trial”, Dr. Michael Shanahan. Dr. Shanahan’s study, most recently published in “Arthritis & Rheumatology” attempts to determine the efficacy of ultrasound-guided genicular nerve block in managing pain in patients with knee osteoarthritis. Dr. Shanahan discusses his team’s methods, results and conclusions of this paper plus some career

en

32:23

Exercise Always Wins: Part 2

ACR Journals On Air ·

2022/11/29

This week, our guest is Dr. Grace Lo, first author of “Association Between Walking for Exercise and Symptomatic and Structural Progression in Individuals with Knee Osteoarthritis: Data from the Osteoarthritis Initiative Cohort” And Assistant Professor at Baylor College of Medicine. The objective of her study: To assess the relationship between walking for exercise and symptomatic and structural disease progression in individuals with knee OA. In this episode, she shares her methods and results with

en

26:56

Genetic Autocorrect and Autoimmunity

ACR Journals On Air ·

2022/11/15

This week on ‘Journals’, Dr. Shanmugam has invited Dr Joann B Sweasy and Dr. Westley Reeves to discuss a paper with an interesting journey, “A Human MSH6 Germline Variant Associated with Systemic Lupus Erythematosus Induces Lupus-Like Disease in Mice“. In this paper, we discover that the science is always telling us something, regardless of where we believe we’re headed and where we ultimately end up. This lupus study has such a story. Join us as our guests explain the study’s objective, the

en

85 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown